The total of 114 patients was divided into CCNB2 low- and high-expression groups according to the expression levels of CCNB2 in tumor tissues; we noticed that 46 patients showed CCNB2 low expression (40.3%, Table 1), and the remaining 68 patients (59.7%) showed high CCNB2 expression. Here, CCNB2 is linked to neoplasm.